Cita APA (7a ed.)

CH, L., MJ, H., SH, C., KC, H., CJ, W., MY, H., . . . SJ, L. (2019). Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]. Dove Medical Press.

Cita Chicago Style (17a ed.)

CH, Lee, et al. Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]. Dove Medical Press, 2019.

Cita MLA (8a ed.)

CH, Lee, et al. Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]. Dove Medical Press, 2019.